ECHO Reducing Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes: TeleECHO - Pretest

According to the American Heart Association (AHA), what is the most important preventative modality for the primary prevention of cardiovascular disease?
 A 54-year-old, overweight male with history of type 2 diabetes mellitus (T2DM) and family history of heart disease presents for regular interval diabetic assessment. His blood sugars are under control with metformin monotherapy, his BP is normal, and his most recent LDL is 195. He takes no other medications. What would be the most appropriate intervention(s) for cardiovascular disease prevention in this patient?
Meta-analyses for SGLT2i trials EMPA-REG, CANVAS and DECLARE-TIMI demonstrated which of the following?
A 61-year-old female with a 10-year history of T2DM treated with metformin presents for diabetes management. She has a BMI of 31, history of left ventricular hypertrophy with intact ejection fraction, lower extremity peripheral arterial disease and an A1C of 7.3. She has had trouble losing weight despite following a Mediterranean diet and daily 30-minute walks. Considering the current ADA-EASD guidelines, intervention with which of the following would be least appropriate for this patient?
Powered by QuestionPro